The integral inventory for depression, a new, self-rated clinimetric instrument for the emotional and painful dimensions in major depressive disorder

International Journal of Psychiatry in Clinical Practice

Volumn 15, Issue 3, 2011, Pages 171-179

  Dueas, Héctor ^a   Lara, Carmen ^b   Walton, Richard J ^c   Granger, Renee E ^c   Dossenbach, Martin ^d   Raskin, Joel ^d  

^a Eli Lilly Mexico   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c ELI LILLY AUSTRALIA PTY LTD   (Australia)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Depression; Pain; Psychiatry; Questionnaires; Reliability and validity

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EMOTION; EXTERNAL VALIDITY; HUMAN; INTEGRAL INVENTORY FOR DEPRESSION; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMETRY; RELIABILITY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

DEPRESSIVE DISORDER, MAJOR; EMOTIONS; FOLLOW-UP STUDIES; HUMANS; OBSERVATION; PAIN; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84860422859     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501.2011.555820     Document Type: Article

References (32)

1. Lépine JP, Briley M. The epidemiology of pain in depression. Hum Psychopharmacol 2004;19(Suppl 1):S3-7.
2. Ohayon MM, Schatzberg AF. Chronic pain and major depressive disorder in the general population. J Psychiatr Res 2010;44(7):454-61.
3. Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. New Engl J Med 1999;341(18): 1329-35.
4. Demyttenaere K, Bonnewyn A, Bruffaerts R, Brugha T, De Graaf R, Alonso J. Comorbid painful physical symptoms and depression: Prevalence, work loss, and help seeking. J Affect Disord 2006;92(2-3):185-93.
5. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: An important outcome in depression. Psychol Med 1995;25(6): 1171-80.
6. Ang QQ, Wing YK, He Y, Sulaiman AH, Chiu NY, Shen YC, et al. Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: A 3-month prospective observational study. Int J Clin Pract 2009;63(7):1041-9.
7. Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. J Psychiatr Res 2005;39(1):43-53.
8. Demyttenaere K, Desaiah D, Petit C, Croenlein J, Brecht S. Patient-assessed versus physician-assessed disease severity and outcome in patients with nonspecifi c pain associated with major depressive disorder. Prim Care Companion J Clin Psychiatry 2009;11(1):8-15.
9. Goldstein DJ, Lu Y, Detke MJ, Hudson J, Iyengar S, Demitrack MA. Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics 2004; 45(1):17-28.
10. Harris CA, D'Eon JL. Psychometric properties of the Beck Depression Inventory-second edition (BDI-II) in individuals with chronic pain. Pain 2008;137(3):609-22.
11. Morley S, Williams AC, Black S. A confi rmatory factor analysis of the Beck Depression Inventory in chronic pain. Pain 2002;99(1-2):289-98.
12. Novy DM, Nelson DV, Berry LA, Averill PM. What does the Beck Depression Inventory measure in chronic pain?: A reappraisal. Pain 1995;61(2):261-70.
13. Poole H, Bramwell R, Murphy P. Factor Structure of the Beck Depression Inventory-II in patients with chronic pain. Clin J Pain 2006;22(9):790-8.
14. S iegert RJ, Walkey FH, Turner-Stokes L. An examination of the factor structure of the Beck Depression Inventory-II in a neurorehabilitation inpatient sample. J Int Neuropsychol Soc 2009;15(1):142-7.
15. Dueñas H, Tapia-Paniagua G, Vazquez-Barquero JL, Acuna A ME, Celis A, Kawas O, et al. Poster: The integral inventory for depression (IID), a new clinimetric tool for the emotional and physically painful dimension of depression. 2nd International Congress of the World Federation of Societies of Biological Psychiatry (WFSBP), 17-21 April 2007, Santiago, Chile.
16. Hung CI, Weng LJ, Su YJ, Liu CY. Preliminary study of a scale measuring depression and somatic symptoms. Psychol Rep 2006;99(2):379-89.
17. Hung CI, Wang SJ, Liu CY. Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder. Depress Anxiety 2009;26(6): 583-91.
18. Hung CI, Weng LJ, Su YJ, Liu CY. Depression and somatic symptoms scale: A new scale with both depression and somatic symptoms emphasized. Psychiatry Clin Neurosci 2006;60(6):700-8.
19. Berwick DM, Murphy JM, Goldman PA, Ware JE Jr, Barsky AJ, Weinstein MC. Performance of a fi ve-item mental health screening test. Med Care 1991;29(2):169-76.
20. Barsky AJ, Wyshak G, Klerman GL. The somatosensory amplifi cation scale and its relationship to hypochondriasis. J Psychiatr Res 1990;24(4):323-34.
21. Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruy FV 3rd, et al. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994;3(9):774-9.
22. Dueñas H, Lee A, Brnabic AJM, Montejo AL, Prakash S, Casimiro-Querubin MLS, et al. Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period. Int J Psychiatry Clin Pract 2010 (submitted).
23. Due ñ as H, Lee A, Brnabic A, Chung K, Lai C, Gamal Badr M, et al. Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study. Int J Psychiatry Clin Pract 2010 (submitted).
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 4th ed. Arlington, VA: American Psychiatric Association; 2000.
25. World Health Organization (WHO). International classifi cation of diseases (ICD-10). Arlington, VA: American Psychiatric Publishing; 1992.
26. Guy W. ECDEU assessment manual for psychopharmacology-revised edition (DHEW Publ No ADM 76-338). Rockville, MD: NIMH Psychopharmacology Research Branch; 1976.
27. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54(5): 573-83.
28. Cronbach L. Coeffi cient alpha and the internal structure of tests. Psychometrika 1951;16(3):297-334.
29. Martínez ME, Marshall JR, Sechrest L. Invited commentary: Factor analysis and the search for objectivity. Am J Epidemiol 1998;148(1):17-19.
30. Bland JM, Altman DG. Cronbach's alpha. Br Med J 1997; 314(7080):572.
31. Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, et al. Correlation between patient and clinician assessments of depression severity in the PREVENT study. Psychiatry Res 2010;177(1-2):177-83.
32. Clarke DM, McKenzie DP. A caution on the use of cutpoints applied to screening instruments or diagnostic criteria. J Psychiatr Res 1994;28(2):185-8.